This study tested whether sarcoplasmic-endoplasmic reticulum Ca 
Endothelin, one of the most potent vasoconstricting peptide released from ECs (35), exerts its effects through two types of sarcolemmal G-protein coupled receptors (GPCRs), ET A and ET B (3, 25) , ET A subtype is profoundly expressed in the VSM and responsible for the constricting effects of ET-1. ET B , on the other hand, is also present at membranes of endothelial cells and VSMC nucleus counteracting pressor effects of ET-1 and preventing nuclear Ca 2+ overload (7).
More than a decade ago ET A receptors were shown to be localized in caveolae in the absence of its ligand (8). A structural unit of caveola, caveolin-1 (Cav-1), appears as a potential Then, ET A receptor antagonist, BQ123, was added to see whether enhanced force was due to uncompensated agonist-induced [Ca 2+ ] i elevation by the removal of SR buffering capacity through CPA-mediated SERCA inhibition. In some arteries, BQ123 showed no inhibition at all. The remaining tone abolished by a purported SOC blocker 2-APB ( Figs. 2A and 2B ).
We also tested the partial contribution of voltage-operated Ca 2+ channels (VOCC) and nonselective cation channels (NSCC) in CPA-enhanced ET-1 response remaining after BQ123.
For this purpose, a VOCC blocker, verapamil (1 µM), and a NSCC blocker, Ni abolished the remaining tone (Fig. 4) .
We also tested if VOCCs are involved in CPA-induced contractions in the absence of any IP 3 -producing receptor activation. For this purpose, a PKC activator, phorboldibutyrate (PDP) was added at low concentration that does not elevate force and cytosolic Ca 
CPA presence did not alter -AR antagonism in PE-induced contractions
In order to investigate whether the decrease in antagonistic effect also occurs for other receptor-mediated responses, a non-peptide vasoconstrictor agonist, phenylephrine (PE) was used. The rationale for using PE was based on the suggestion that K 1 -adrenergic receptors (K 1 -AR) could be an essential component of TRPC6 (12), a candidate transient receptor potential channel subtype for SOC entry. Another reason of using PE was that K 1 -ARs may not participate in caveola-associated receptor trafficking (9). Therefore, a similar experimental procedure was also performed with PE.
Contractions induced by submaximal concentrations (300 nM) of PE (pD 2 =7.32±0.04, n=3) were sensitive to K 1 -AR selective antagonist, prazosin (1 µM) ( 
